For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231129:nRSc9803Ua&default-theme=true
RNS Number : 9803U Benchmark Holdings PLC 29 November 2023
29 November 2023
Benchmark Holdings plc
("Benchmark" or the "Company")
Directorate Change
The Company is pleased to announce the appointment of Jonathan Esfandi as
Non-Executive Director. Mr Esfandi is the founder and managing partner at JNE
Partners LLP.
Mr. Esfandi will act as shareholder representative of JNE Partners LLP, a
significant shareholder of the Company, and therefore the Board has concluded
that he is not an independent director.
Laura Lavers, who joined the Board in November 2022, will retire from the
Board as a Non-Executive Director with effect from today.
Peter George, Chairman, commented:
"We welcome Jonathan to the Board and look forward to working together. On
behalf of the Board, I wish to thank Laura Lavers for her contribution over
the past year."
The following information is disclosed in accordance with Rule 17 and
paragraph (g) of Schedule 2 of the AIM Rules for Companies in connection with
the appointment of Jonathan to the Board of the Company:
Full Name: Jonathan Esfandi
Age: 49
Current Directorships:
JNE PARTNERS LLP
JNE PARTNERS (UK) SERVICES LTD
Former Directorships (previous five years): None within the past five years
Beneficial interest in the equity securities of Benchmark Holdings plc: No
direct beneficial interest. Funds managed by JNE Partners LLP have a holding
of 169,263,811 shares in Benchmark
There is no further information required to be disclosed under Rule 17 or
paragraph (g) of Schedule 2 of the AIM Rules for Companies.
Enquiries
For further information, please contact:
Benchmark Holdings plc Tel: 0114 240 9939
Trond Williksen, CEO
Septima Maguire, CFO
Ivonne Cantu, Investor Relations
Deutsche Numis (Nominated Adviser and Broker) Tel: 020 7260 1000
Freddie Barnfield, Duncan Monteith, Sher Shah
MHP Tel: 020 3128 8004
Katie Hunt, Reg Hoare benchmark@mhpgroup.com
Equity Development Tel: 020 7065 2692
Hannah Crowe
About Benchmark
Benchmark is a leading aquaculture biotechnology company. Benchmark's mission
is to enable aquaculture producers to improve their sustainability and
profitability.
We bring together biology and technology to develop innovative products and
solutions which improve yield, quality and animal health and welfare for our
customers. We do this by improving the genetic make-up, health and nutrition
of their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon
eggs, live feed (Artemia), specialist diets and probiotics and sea lice
treatments. Find out more at www.benchmarkplc.com
(http://www.benchmarkplc.com/) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOADXBDBXGDDGXI